In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 44 for your search:
Drug:  pegaspargase
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 12 months to 21 years
Sponsor: NCI
Protocol IDs: POG-9006

2.

Phase: Phase III
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: DFCI-91001, NCI-T91-0059D, T91-0059

3.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 22
Sponsor: NCI
Protocol IDs: POG-9295

4.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to 21 years
Sponsor: NCI
Protocol IDs: POG-9202

5.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 12 months to 21 years
Sponsor: NCI
Protocol IDs: POG-9203

6.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to under 31
Sponsor: NCI, Other
Protocol IDs: AALL0232, COG-AALL0232, CDR0000349182, NCT00075725

7.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to under 10
Sponsor: NCI, Other
Protocol IDs: AALL0331, COG-AALL0331, CDR0000409589, NCT00103285

8.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to under 30
Sponsor: NCI, Other
Protocol IDs: AALL0433, NCI-2009-00306, COG-AALL0433, CDR0000495359, U10CA098543, NCT00381680

9.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to 17
Sponsor: NCI, Other
Protocol IDs: 05-001 / CDR0000513019, P01CA068484, P30CA006516, DFCI-05001, NCT00400946

10.

Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: ID03-0124, NCI-2010-01997, NCT00452439

11.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 1 to 30
Sponsor: NCI
Protocol IDs: NCI-2009-00312, CDR0000600217, COG-AALL0622, AALL0622, U10CA098543, NCT00720109

12.

Phase: Phase III
Type: Supportive care, Treatment
Status: Unknown
Age: 25 to 65
Sponsor: Other
Protocol IDs: UCL-08-0167, UCL/08/0167, EU-21009, EUDRACT-2009-012717-22, UCL-UKALL14, MREC-09-H0711-90, NCRI-UCL-08-0167, CRUK-C27995-A9609, NCT01085617

13.

Phase: Phase III
Type: Behavioral study, Treatment
Status: Closed
Age: 1 to under 31
Sponsor: NCI
Protocol IDs: NCI-2009-00307, CDR0000514500, COG-AALL0434, AALL0434, U10CA098543, NCT00408005

14.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: over 1 to 21
Sponsor: NCI
Protocol IDs: POG-9061

15.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: under 30
Sponsor: NCI
Protocol IDs: ENZON-ASP-305, NCI-91-C-116, NCI-T91-0129N, T91-0129

16.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: ENZON-ASP-107, NCI-V93-0255

17.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 2 to 31
Sponsor: NCI, Other
Protocol IDs: ADVL04P2, NCI-2011-01624, COG-ADVL04P2, CDR0000396777, U10CA098543, NCT00098839

18.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: Over 1 and under 21
Sponsor: Other
Protocol IDs: T2005-003, NCT00440726

19.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: BGSM-24186, NCI-V86-0044

20.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-8866

21.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 1 to 20
Sponsor: NCI
Protocol IDs: NCI-92-C-0049E, CCG-1911, NCI-T91-0187N, T91-0187

22.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-9297

23.

Phase: Phase II
Type: Treatment
Status: Closed
Age: under 22 at initial diagnosis
Sponsor: NCI
Protocol IDs: POG-9310

24.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 64
Sponsor: NCI, Other
Protocol IDs: CDR0000426447, U10CA032102, S0333, SWOG-S0333, NCT00109837

25.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 55
Sponsor: Other
Protocol IDs: 9L-03-1, NCT00184041
1   
New Search